Investors in the medical cannabis space may want to diversify beyond companies providing treatments, such as Medical Marijuana Inc. (MJNA), and into companies like Novus that are providing high-value ancillary services with limited competition.
As medical cannabis continues to grow in popularity, driven by new research showing efficacy, the company could be positioned for growth ahead.